Craig-Hallum Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $11
Portfolio Pulse from richadhand@benzinga.com
Craig-Hallum analyst Jeff Van Rhee has initiated coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and a price target of $11.
July 19, 2023 | 11:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cellebrite DI (NASDAQ:CLBT) has been initiated with a Buy rating by Craig-Hallum, with a price target of $11.
The initiation of coverage by Craig-Hallum with a Buy rating and a price target of $11 indicates a positive outlook for Cellebrite DI. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100